Hyaluronic Acid Accelerates VEGF and PDGF Release from Advance Platelet Rich Fibrin in Diabetic Foot Ulcer

Ronald Winardi Kartika, Idrus Alwi, Franciscus Dhyanagiri Suyatna, Ferry Sandra, Em Yunir, Sarwono Waspadji, Suzzana Immanuel, Todung Silalahi, Saleha Sungkar, Jusuf Rachmat, Saptawati Bardosono, Mirta Hediyati Reksodiputro

Abstract


BACKGROUND: Hyaluronic acid (HA) is an essential component of extracellular matrix and mediates signaling in wound healing. HA could induce growth factor release from Advanced Platelet Rich Fibrin (A-PRF), including Vascular Endothelial Growth Factor (VEGF) and Platelet-derived Growth Factor (PDGF). However, concentrations of the released-VEGF and PDGF have not been clearly disclosed. Therefore, current study was conducted to measure the release of these growth factors in HA + A-PRF gel of diabetic foot ulcer (DFU) subjects.

METHODS: Twenty DFU subjects were included in the study and treated with A-PRF or HA+A-PRF. A-PRF was derived from autologous peripheral blood and processed with low-speed centrifugation. HA was added with a ratio of 1:0.6. A-PRF or HA + A-PRF was applied topically on DFU. Upper tips of A-PRF or HA + A-PRF gels were collected on day 0, 3 and 7 for measurements of VEGF and PDGF concentrations with Enzyme-linked Immune-sorbent Assay (ELISA) methods.

RESULTS: On day-3, both VEGF and PDGF concentrations of HA + A-PRF group were significantly higher than the VEGF (p=0.000) and PDGF (p=0.019) concentrations of A-PRF group. The VEGF and PDGF concentrations were continuously and significantly increased on day-7 of HA + A-PRF group, compared to the VEGF (p=0.000) and PDGF (p=0.004) concentrations of A-PRF group.

CONCLUSION: Combination HA+A-PRF induces VEGF and PDGF release from A-PRF. A mixture of A-PRF and HA could be more effective than A-PRF alone for treatment of DFU.

KEYWORDS: hyaluronic acid, advanced platelet rich fibrin, PRF, growth factor, VEGF, PDGF, diabetic foot ulcer


Full Text:

PDF

References


Bhanot S, Alex JC. Current applications of platelet gels in facial plastic surgery. Facial Plast Surg. 2002; 18: 27-33, CrossRef.

Oktaviono YH, Susanti M, Lefi A, Sandra F. Human umbilical cord blood-derived secretome enhance endothelial progenitor cells migration on hyperglycemic conditions. Pharmacogn J. 2020; 12: 793-7, CrossRef.

Dewi DAR, Sandra F. Conditioned media of human umbilical cord blood mesenchymal stem cell inhibits ultraviolet B-induced apoptosis in fibroblasts. Indones Biomed J. 2019, 11: 85-90, CrossRef.

Whitman DH, Berry RL, Green DM. Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1997; 55: 1294-9, CrossRef.

Soffer E, Ouhayoun JP, Anagnostou F. Fibrin sealants and platelet preparations in bone and periodontal healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003; 95: 521-8, CrossRef.

Mazzucco L, Medici D, Serra M, Panizza R, Rivara G, Orecchia S, et al. The use of autologous platelet gel to treat difficult-toheal wounds: a pilot study. Transfusion. 2004; 44: 1013-8, CrossRef.

Borzini P, Mazzucco L. Platelet gels and releasates. Curr Opin Hematol. 2005; 12: 473-9, CrossRef.

Everts PA, Knape JT, Weibrich G, Schonberger JP, Hoffmann J, Overdevest EP, et al. Platelet-rich plasma and platelet gel: a review. J Extra Corpor Technol. 2006; 38: 174-87, PMID.

Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004; 91: 4-15, CrossRef.

Lind M. Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation. Acta Orthop Scand Suppl. 1998; 283: 2-37, PMID.

Kandziora F, Pflugmacher R, Scholz M, Schafer J, Schollmeier G, Schmidmaier G, et al. Dose-dependent effects of combined IGF-I and TGF-beta1 application in a sheep cervical spine fusion model. Eur Spine J. 2003; 12: 464-73, CrossRef.

Kartika RW, Alwi I, Suyatna FD, Yunir E, Waspadji S, Immanuel S, et al. Advance-platelet rich fibrin and hyaluronic acid combination improves interleukin-6 and granulation index in diabetic foot ulcer patients. Indones Biomed J. 2021; 13: 170-7, CrossRef.

Schmidt MB, Chen EH, Lynch SE. A review of the effects of insulin-like growth factor and platelet derived growth factor on in vivo cartilage healing and repair. Osteoarthritis Cartilage. 2006; 14: 403-12, CrossRef.

Marx RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004; 62: 489-96, CrossRef.

Meilana A, Dewi NM, Wijaya A. Stem cell therapy in wound healing and tissue regeneration. Indones Biomed J. 2016; 8: 61-70, CrossRef.

Levett PA, Hutmacher DW, Malda J. Hyaluronic acid enhances the mechanical properties of tissue-engineered cartilage constructs. PLoS One. 2014; 9: e113216, CrossRef.

Azyenela R, Julianto I, Widodo Y, Wirohadidjojo. The addition of hyaluronic acid into platelet-rich fibrin lysate in restoration of senescent human dermal fibroblasts activities. Malays J Med Biol Res. 2016; 3: 1-8, CrossRef.

Sargowo D, Handaya AY, Widodo MA, Lyrawati D, Tjokroprawiro A. Aloe gel enhances angiogenesis in healing of diabetic wound. Indones Biomed J. 2011; 3: 204-15, CrossRef.

Choukroun J, Diss A, Simonpieri A, Girard MO, Schoeffler C, Dohan SL, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part IV: clinical effects on tissue healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006; 101: 56-60, CrossRef.

Sandra F, Oktaviono YH, Widodo MA, Dirgantara Y, Chouw A, Sargowo D. Endothelial progenitor cells proliferated via MEK-dependent p42 MAPK signaling pathway. Mol Cell Biochem. 2015; 400: 201-6, CrossRef.

Oktaviono YH, Putri AY, Al-Farabi MJ, Firmansyah YR, Sandra F. Extracellular-signal regulated kinase signalling pathway mediates the increased proliferation of EPCs treated with garlic (Allium sativum) extract, purple sweet potato (Ipomoea batatas) extract, and vitamin C. Pharmacogn J. 2020; 12: 442-7, CrossRef.

Hendarmin L, Sandra F, Nakao Y, Ohishi M, Nakamura N. TNFα played a role in induction of Akt and MAPK signals in ameloblastoma. Oral Oncol. 2005; 41: 375-82,

Hall CL, Lange LA, Prober DA, Zhang S, Turley EA. pp60(c-src) is requiredfor cell locomotion regulated by the hyaluronanreceptor RHAMM. Oncogene. 1996; 13: 2213-24, PMID.

Savani RC, Cao G, Pooler PM, Zaman A, Zhou Z, DeLisser HM. Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem. 2001; 276: 36770-8, CrossRef.

Slevin M, Krupinski J, Kumar S, Gaffney J.Angiogenic oligosaccharides ofhyaluronan induce protein tyrosine kinase activity in endothelial cells andactivate a cytoplasmic signal transduction pathway resulting in proliferation. Lab Invest. 1998; 78: 987-1003, PMID.

Hu Y, Wu Y, Cai J, Ma S, Wang X. The procoagulant properties of hyaluronic acid-collagen (I)/chitosan complex film. J Biomater Sci Plym Ed. 2009; 20: 111-8, CrossRef.

Bourguignou LY, Singleton PA, Zhu H. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. J Biol Chem. 2002; 277: 303-12, CrossRef.




DOI: https://doi.org/10.18585/inabj.v13i3.1523

Indexed by:

                 

                  

               

  

 

The Prodia Education and Research Institute